CIK: 0001056807 · Show all filings
Period: Q3 2018 (← Previous) (Next →)
Filing Date: Nov 14, 2018
Total Value ($000): $1,137,993 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | ARRAY BIOPHARMA INC | 6,290,586 | $95,617 | 8.4% | $10.14 | — | COM | 04269X105 |
| — | CHEMOCENTRYX INC | 6,773,760 | $85,620 | 7.5% | $8.94 | — | COM | 16383L106 |
| — | MERUS N V | 3,914,913 | $77,280 | 6.8% | $20.15 | — | COM | N5749R100 |
| CYTK | CYTOKINETICS INC | 5,186,839 | $51,090 | 4.5% | $10.41 | -23.0% | COM NEW | 23282W605 |
| — | FIVE PRIME THERAPEUTICS INC | 3,381,117 | $47,065 | 4.1% | $14.55 | — | COM | 33830X104 |
| — | BLUEPRINT MEDICINES CORP | 598,267 | $46,701 | 4.1% | $25.16 | — | COM | 09627Y109 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 15,232,268 | $41,279 | 3.6% | $2.80 | -26.1% | COM | 45665G303 |
| KURA | KURA ONCOLOGY INC | 2,015,856 | $35,277 | 3.1% | $11.97 | +60.2% | COM | 50127T109 |
| — | MIRATI THERAPEUTICS INC | 723,322 | $34,068 | 3.0% | $49.30 | — | COM | 60468T105 |
| — | ARQULE INC | 5,827,902 | $32,986 | 2.9% | $1.75 | — | COM | 04269E107 |
| XNCR | XENCOR INC | 837,538 | $32,639 | 2.9% | $26.15 | +55.9% | COM | 98401F105 |
| — | PIERIS PHARMACEUTICALS INC | 5,600,521 | $31,363 | 2.8% | $4.51 | — | COM | 720795103 |
| — | BIOLINERX LTD | 25,995,575 | $27,815 | 2.4% | $1.01 | — | SPONSORED ADR | 09071M106 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 2,617,967 | $26,939 | 2.4% | $9.71 | -11.4% | COM | 74366E102 |
| IONS | IONIS PHARMACEUTICALS INC | 520,000 | $26,822 | 2.4% | $44.30 | +6.0% | COM | 462222100 |
| XOMA | XOMA CORP DEL | 1,502,800 | $26,404 | 2.3% | $5.35 | +274.6% | COM NEW | 98419J206 |
| ANAB | ANAPTYSBIO INC | 250,265 | $24,969 | 2.2% | $23.32 | +255.8% | COM | 032724106 |
| — | GALMED PHARMACEUTICALS LTD | 1,761,567 | $23,922 | 2.1% | $11.90 | — | SHS | M47238106 |
| — | CONCERT PHARMACEUTICALS INC | 1,592,138 | $23,627 | 2.1% | $14.18 | — | COM | 206022105 |
| — | FORWARD PHARMA A/S | 8,502,925 | $19,387 | 1.7% | $5.84 | — | SPONSORED ADR | 34986J105 |
| — | DICERNA PHARMACEUTICALS INC | 1,152,073 | $17,581 | 1.5% | $15.26 | — | COM | 253031108 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,890,507 | $16,221 | 1.4% | $10.04 | -0.4% | COM | 221015100 |
| ACIU | AC IMMUNE SA | 2,017,500 | $16,140 | 1.4% | $10.05 | 0.0% | SHS | H00263105 |
| — | IMMUNE DESIGN CORP | 4,658,353 | $16,071 | 1.4% | $3.52 | — | COM | 45252L103 |
| SPRO | SPERO THERAPEUTICS INC | 1,488,088 | $15,640 | 1.4% | $12.08 | -3.9% | COM | 84833T103 |
| XENE | XENON PHARMACEUTICALS INC | 1,165,553 | $15,385 | 1.4% | $9.58 | +20.9% | COM | 98420N105 |
| — | MOLECULAR TEMPLATES INC | 2,787,629 | $15,025 | 1.3% | $5.78 | — | COM | 608550109 |
| — | CTI BIOPHARMA CORP | 6,929,690 | $14,968 | 1.3% | $3.77 | — | COM NEW | 12648L601 |
| RCUS | ARCUS BIOSCIENCES INC | 1,058,840 | $14,760 | 1.3% | $16.29 | -21.7% | COM | 03969F109 |
| REPL | REPLIMUNE GROUP INC | 911,852 | $14,681 | 1.3% | $17.53 | 0.0% | COM | 76029N106 |
| — | VERASTEM INC | 1,986,994 | $14,406 | 1.3% | $3.05 | — | COM | 92337C104 |
| KALV | KALVISTA PHARMACEUTICALS INC | 609,014 | $13,465 | 1.2% | $13.52 | 0.0% | COM | 483497103 |
| — | CALITHERA BIOSCIENCES INC | 2,544,000 | $13,356 | 1.2% | $5.25 | — | COM | 13089P101 |
| — | MEI PHARMA INC | 3,080,308 | $13,276 | 1.2% | $3.94 | — | COM NEW | 55279B202 |
| — | SPRING BK PHARMACEUTICALS INC | 953,301 | $11,487 | 1.0% | $13.40 | — | COM | 849431101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 1,233,618 | $9,968 | 0.9% | $9.90 | -28.0% | COM | 87164F105 |
| — | ONCOMED PHARMACEUTICALS INC | 4,042,989 | $8,571 | 0.8% | $8.77 | — | COM | 68234X102 |
| — | CIDARA THERAPEUTICS INC | 1,930,670 | $8,495 | 0.7% | $5.20 | — | COM | 171757107 |
| — | VBI VACCINES INC | 3,100,000 | $7,502 | 0.7% | $4.27 | — | COM NEW | 91822J103 |
| — | ALBIREO PHARMA INC | 218,800 | $7,212 | 0.6% | $32.57 | — | COM | 01345P106 |
| — | CONTRAFECT CORP | 3,478,326 | $7,200 | 0.6% | $1.14 | — | COM | 212326102 |
| — | PRINCIPIA BIOPHARMA INC | 240,000 | $7,013 | 0.6% | $29.22 | — | COM | 74257L108 |
| — | MERRIMACK PHARMACEUTICALS INC | 1,110,588 | $5,919 | 0.5% | $4.91 | — | COM NEW | 590328209 |
| ARGX | ARGENX SE | 76,808 | $5,825 | 0.5% | $75.84 | — | SPONSORED ADR | 04016X101 |
| — | TESARO INC | 140,000 | $5,461 | 0.5% | $39.01 | — | COM | 881569107 |
| — | ERYTECH PHARMA | 625,000 | $5,450 | 0.5% | $22.02 | — | SPONSORED ADR | 29604W108 |
| — | GENOCEA BIOSCIENCES INC | 5,265,000 | $4,105 | 0.4% | $1.04 | — | COM | 372427104 |
| — | ALPINE IMMUNE SCIENCES INC | 643,059 | $4,071 | 0.4% | $11.60 | — | COM | 02083G100 |
| — | SURFACE ONCOLOGY INC | 360,218 | $3,941 | 0.3% | $15.92 | — | COM | 86877M209 |
| — | SUNESIS PHARMACEUTICALS INC | 1,684,636 | $3,369 | 0.3% | $3.60 | — | COM PAR | 867328700 |
| — | REGULUS THERAPEUTICS INC | 13,685,204 | $2,704 | 0.2% | $1.20 | — | COM | 75915K101 |
| — | ADURO BIOTECH INC | 287,776 | $2,115 | 0.2% | $9.30 | — | COM | 00739L101 |
| — | VICAL INC | 1,332,605 | $1,826 | 0.2% | $1.83 | — | COM NEW | 925602203 |
| — | ESSA PHARMA INC | 576,771 | $1,731 | 0.2% | $3.75 | — | COM NEW | 29668H708 |
| — | REALM THERAPEUTICS PLC | 360,866 | $1,173 | 0.1% | $3.25 | — | SPONSORED ADS | 75606L103 |
| — | LOXO ONCOLOGY INC | 4,089 | $699 | 0.1% | $53.87 | — | COM | 548862101 |
| — | ZYMEWORKS INC | 19,804 | $311 | 0.0% | $14.79 | — | COM | 98985W102 |